ADAM17 and hepatocellular carcinoma: Interestingly, the expression of the metalloproteinase ADAM17/TACE is significantly induced in HCC and in the liver of cirrhotic patients [39,56] suggesting an increased availability of EGFR ligands from the early stages of hepatocarcinogenesis and reinforcing the implication of EGFR system in this process.